Ventas (NYSE:VTR) Price Target Raised to $99.00 at Royal Bank Of Canada

Ventas (NYSE:VTR) had its price objective raised by Royal Bank Of Canada from $98.00 to $99.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Royal Bank Of Canada’s price target points to a potential upside of 8.58% from the stock’s previous close.

VTR has been the subject of several other research reports. Scotiabank decreased their price target on Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $100.00 target price on shares of Ventas in a report on Tuesday, June 16th. Evercore reissued an “outperform” rating and set a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. JPMorgan Chase & Co. raised their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Finally, BMO Capital Markets boosted their price target on shares of Ventas from $105.00 to $107.00 and gave the stock an “outperform” rating in a research report on Tuesday. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $98.00.

Ventas Trading Up 1.0%

NYSE:VTR traded up $0.89 during trading hours on Friday, hitting $91.17. 487,959 shares of the company were exchanged, compared to its average volume of 3,639,736. The stock has a market capitalization of $46.77 billion, a price-to-earnings ratio of 168.92, a price-to-earnings-growth ratio of 2.05 and a beta of 0.69. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. Ventas has a one year low of $66.38 and a one year high of $101.60. The company has a fifty day simple moving average of $90.26 and a 200 day simple moving average of $86.50.

Insider Transactions at Ventas

In related news, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.53% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ventas

A number of institutional investors and hedge funds have recently made changes to their positions in VTR. Dynamic Wealth Strategies LLC acquired a new stake in shares of Ventas in the 1st quarter valued at about $25,000. Silvant Capital Management LLC bought a new position in Ventas in the second quarter worth approximately $28,000. Meeder Asset Management Inc. bought a new position in Ventas in the second quarter worth approximately $30,000. Wiser Advisor Group LLC acquired a new stake in Ventas in the third quarter valued at approximately $27,000. Finally, IFC & Insurance Marketing Inc. acquired a new stake in Ventas in the fourth quarter valued at approximately $30,000. Institutional investors own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.